1-3 of 3
Archie N. Tse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

Archie N. Tse, David S. Klimstra, Mithat Gonen, Manish Shah, Tahir Sheikh, Rachel Sikorski, Richard Carvajal, Janet Mui, Caroll Tipian, Eileen O'Reilly, Ki Chung, Robert Maki, Robert Lefkowitz, Karen Brown, Katia Manova-Todorova, Nian Wu, Merrill J. Egorin, David Kelsen, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6704–6711.
https://doi.org/10.1158/1078-0432.CCR-08-1006
Published: 16 October 2008
View article titled, A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
Open the PDF for A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Targeting Checkpoint Kinase 1 in Cancer Therapeutics

Archie N. Tse, Richard Carvajal, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 1955–1960.
https://doi.org/10.1158/1078-0432.CCR-06-2793
Published: 02 April 2007
View article titled, Targeting Checkpoint Kinase 1 in Cancer Therapeutics
Open the PDF for Targeting Checkpoint Kinase 1 in Cancer Therapeutics in another window
Journal Articles

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo

Archie N. Tse, Katherine G. Rendahl, Tahir Sheikh, Haider Cheema, Kim Aardalen, Millicent Embry, Sylvia Ma, Edward J. Moler, Zhi Jie Ni, Daniel E. Lopes de Menezes, Barbara Hibner, Thomas G. Gesner, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 591–602.
https://doi.org/10.1158/1078-0432.CCR-06-1424
Published: 25 January 2007
View article titled, CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <em>In vitro</em> and <em>In vivo</em>
Open the PDF for CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <em>In vitro</em> and <em>In vivo</em> in another window
Includes: Supplementary data